Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Formulation Development

Background:

• Celecoxib, a non-steroidal anti-inflammatory drug, often requires enhanced delivery systems for improved bioavailability.
• Self-microemulsifying drug delivery systems (SMEDDS) offer a promising approach for formulating poorly soluble drugs like celecoxib.
• Optimization of SMEDDS is crucial for achieving desired droplet size and drug release characteristics.

Purpose of the Study:

• To prepare, evaluate, and optimize SMEDDS for celecoxib.
• To investigate the impact of key excipients on droplet size.
• To establish a reliable predictive model for SMEDDS formulation.

Main Methods:

• A 3-factor, 3-level factorial design was employed for optimization.
• Labrafil 2609 WL, Labrasol, and Cremophor EL were used as independent variables.
• Droplet size after dilution in 0.1N HCl was the primary response variable.

Main Results:

• A regression equation was developed to correlate independent variables with particle size (Y).
• The optimized formulation predicted a particle size of 28.33 nm.
• Observed particle sizes closely matched predicted values, validating the optimization model.

Conclusions:

• The factorial design effectively optimized celecoxib SMEDDS.
• The developed mathematical model reliably predicts particle size for SMEDDS.
• This study demonstrates a robust approach for developing optimized celecoxib SMEDDS.